Stockscreener 앱 받기
2.27
0.44%
0.01
시간 외 거래:
2.23
-0.04
-1.76%
전일 마감가:
$2.26
열려 있는:
$2.225
하루 거래량:
118.50K
Relative Volume:
0.09
시가총액:
$23.63M
수익:
-
순이익/손실:
$-45.57M
주가수익비율:
-0.3603
EPS:
-6.3
순현금흐름:
$-38.56M
1주 성능:
+9.13%
1개월 성능:
-1.30%
6개월 성능:
+33.53%
1년 성능:
-21.72%
1일 변동 폭
$2.20
$2.30
1주일 범위
$2.05
$2.34
52주 변동 폭
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
명칭
Sab Biotherapeutics Inc
전화
305-845-2813
주소
777 W 41ST ST, MIAMI BEACH
SABS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
2.27 | 23.53M | 0 | -45.57M | -38.56M | -6.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 재개 | H.C. Wainwright | Buy |
| 2024-10-09 | 개시 | Craig Hallum | Buy |
| 2024-08-28 | 개시 | Oppenheimer | Outperform |
| 2021-11-05 | 개시 | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc 주식(SABS)의 최신 뉴스
What indicators show strength in SAB Biotherapeutics Inc. Equity WarrantQuarterly Investment Review & Capital Efficient Trade Techniques - Newser
Applying Wyckoff theory to SAB Biotherapeutics Inc. stockEarnings Trend Report & Expert Approved Momentum Ideas - Newser
Is SAB Biotherapeutics Inc. Equity Warrant forming a double bottomEarnings Miss & Low Risk Growth Stock Ideas - خودرو بانک
SAB Biotherapeutics Inc. Equity Warrant stock trend outlook and recovery pathRate Cut & Consistent Return Strategy Ideas - Newser
Applying chart zones and confluence areas to SAB Biotherapeutics Inc. Equity WarrantMarket Performance Summary & AI Driven Price Forecasts - Newser
Risk adjusted return profile for SAB Biotherapeutics Inc. Equity Warrant analyzed - Newser
Real time scanner hits for SAB Biotherapeutics Inc. explainedWeekly Profit Report & Community Trade Idea Sharing - Newser
Can SAB Biotherapeutics Inc. Equity Warrant disrupt its industryWeekly Investment Recap & Technical Pattern Based Buy Signals - خودرو بانک
SAB Biotherapeutics Inc. stock daily chart insightsWeekly Market Report & AI Enhanced Trade Execution Alerts - Newser
Has SAB Biotherapeutics Inc. Equity Warrant found a price floorWeekly Trade Review & Real-Time Buy Signal Notifications - Newser
Visualizing SAB Biotherapeutics Inc. stock with heatmaps2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
Is SAB Biotherapeutics Inc. a good stock for dollar cost averagingQuarterly Earnings Summary & AI Driven Price Predictions - خودرو بانک
Tools to monitor SAB Biotherapeutics Inc. recovery probability2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Why SAB Biotherapeutics Inc. Equity Warrant is moving todayWall Street Watch & Low Drawdown Investment Ideas - Newser
Can SAB Biotherapeutics Inc. Equity Warrant hit a new high this monthForecast Cut & Daily Profit Focused Screening - Newser
SAB Biotherapeutics Inc. Equity Warrant stock volume spike explainedWeekly Risk Summary & Entry Point Confirmation Signals - Newser
Order flow analysis tools used on SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Reactions & Safe Capital Growth Tips - Newser
Heatmap analysis for SAB Biotherapeutics Inc. and competitorsJuly 2025 Pullbacks & Weekly High Potential Stock Alerts - Newser
SAB Biotherapeutics Inc. stock chart pattern explainedMarket Performance Recap & Real-Time Sentiment Analysis - Newser
What the charts say about SAB Biotherapeutics Inc. todayJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - Newser
Using data tools to time your SAB Biotherapeutics Inc. exit2025 Key Highlights & Community Verified Swing Trade Signals - Newser
News impact scoring models applied to SAB Biotherapeutics Inc.2025 Momentum Check & Consistent Profit Trading Strategies - Newser
SAB Biotherapeutics Inc. Equity Warrant stock trend forecast2025 Dividend Review & Verified Entry Point Detection - Newser
Ranking SAB Biotherapeutics Inc. among high performing stocks via toolsTrade Analysis Report & Real-Time Volume Surge Alerts - Newser
Chart overlay techniques for tracking SAB Biotherapeutics Inc. Equity WarrantMarket Trend Summary & Accurate Trade Setup Notifications - Newser
SAB Biotherapeutics Inc. stock momentum explainedPortfolio Risk Report & AI Driven Price Predictions - Newser
What is SAB Biotherapeutics Inc. Equity Warrant s revenue forecastQuarterly Portfolio Summary & AI Forecast for Swing Trade Picks - خودرو بانک
Combining price and volume data for SAB Biotherapeutics Inc.Quarterly Market Review & AI Enhanced Execution Alerts - Newser
Chart based analysis of SAB Biotherapeutics Inc. Equity Warrant trendsJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - Newser
What machine learning models say about SAB Biotherapeutics Inc.Weekly Gains Report & Detailed Earnings Play Strategies - Newser
Should you buy the dip on SAB Biotherapeutics Inc.2025 Pullback Review & Accurate Buy Signal Alerts - خودرو بانک
Price momentum metrics for SAB Biotherapeutics Inc. explained2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Is SAB Biotherapeutics Inc. exposed to political riskWeekly Stock Report & Intraday High Probability Setup Alerts - خودرو بانک
Breakthrough Type 1 Diabetes Treatment: SAB BIO to Showcase Novel Immunotherapy SAB-142 in 5 EASD Sessions - Stock Titan
SAB BIO to Deliver Five Presentations Related to SAB-142 at - GlobeNewswire
Using economic indicators to assess SAB Biotherapeutics Inc. potentialWeekly Profit Analysis & Fast Entry Momentum Alerts - Newser
Will SAB Biotherapeutics Inc. outperform the marketJuly 2025 Earnings & Trade Opportunity Analysis Reports - Newser
Will SAB Biotherapeutics Inc. Equity Warrant rebound enough to break evenMarket Growth Summary & Breakout Confirmation Alerts - Newser
What’s next for SAB Biotherapeutics Inc. stockNew Guidance & Long-Term Investment Growth Plans - خودرو بانک
Is SAB Biotherapeutics Inc. Equity Warrant undervalued by DCF analysisCPI Data & Low Risk High Win Rate Picks - khodrobank.com
Using fundamentals and technicals on SAB Biotherapeutics Inc.Weekly Trend Recap & AI Powered Trade Plan Recommendations - Newser
What candlestick patterns are forming on SAB Biotherapeutics Inc.Weekly Investment Recap & AI Based Buy and Sell Signals - Newser
What to expect from SAB Biotherapeutics Inc. Equity Warrant in the next 30 daysDollar Strength & Long-Term Growth Portfolio Plans - Newser
Key resistance and support levels for SAB Biotherapeutics Inc.2025 Big Picture & Reliable Intraday Trade Plans - Newser
How to build a dashboard for SAB Biotherapeutics Inc. Equity Warrant stockJuly 2025 PreEarnings & Stock Portfolio Risk Control - Newser
Sab Biotherapeutics Inc (SABS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):